|
 |
|
 |
|
 |
| |
| • |
Surat, India - August 10, 2010 - Sahajanand Medical Technologies, a leading developer and manufacturer of Drug Eluting Stents announced the Company's participation in the TCT 2010 Conference, to be held September 21-25, 2010 Read More...
|
| • |
Paris, France - May 25-28, 2010 - Sahajanand Medical Technologies, a leading developer and manufacturer of Drug Eluting Stents, is present at the EuroPCR 2010- the leading cardiovascular course. Read More... |
|
|
|
|
|
|
|
|
 |
Supralimus-Core™ Sirolimus Eluting Coronary Stent System is based on the
three powerful... Learn More... |
|
|
|
 |
The Supralimus®
is based on the three powerful tools. The CE approved The
Millennium Matrix® Stent... Learn More... |
|
|
|
 |
The Coronnium® (CE approved)
Cobalt Chromium Coronary Stent System contains... Learn More... |
|
|
|
 |
The Infinnium®
(CE approved)
Paclitaxel
Eluting Coronary Stent System contains Biodegradable... Learn More... |
|
|
|
 |
The Millennium Matrix®
(CE approved)
Coronary Stent System contains excellent technical features
like... Learn More... |
|
|
|
ShareThis |
